Yazdi K. Pithavala

Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results

Hope S. Rugo, Roy S. Herbst, Glenn Liu et al. · Journal of Clinical Oncology · 2005 · 485 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Pharmacodynamic Measure of Response After Acute Dosing of AG-013736, an Oral Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors: Results From a Phase I Study

Glenn Liu, Hope S. Rugo, George Wilding et al. · Journal of Clinical Oncology · 2005 · 260 citations

Medicine, Oncology, Pharmacology +15

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

Jean‐Philippe Spano, Catherine Chodkiewicz, Joan Maurel et al. · The Lancet · 2008 · 249 citations

Medicine, Oncology, Pharmacology +8

Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial

Brian I. Rini, Bohuslav Melichar, Takeshi Ueda et al. · The Lancet Oncology · 2013 · 232 citations · Full text

Medicine, Oncology, Pharmacology +11

Axitinib in Metastatic Renal Cell Carcinoma: Results of a Pharmacokinetic and Pharmacodynamic Analysis

Brian I. Rini, May Garrett, Bill Poland et al. · The Journal of Clinical Pharmacology · 2013 · 136 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16